2026 Global: Microbiome Sequencing Services Market-Competitive Review (2032) report
Description
The 2026 Global: Microbiome Sequencing Services Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Leading players in the Microbiome Sequencing Services Market include Illumina, Novogene, BGI Genomics, and Macrogen, whose capacities span 16S rRNA gene sequencing, whole-genome shotgun sequencing, metagenomic profiling, and cutting-edge library preparation. Illumina, headquartered in San Diego, United States, is recognized for scalable platforms and broad service offerings that support large-cohort microbiome studies. Novogene, headquartered in Beijing, China, combines high-throughput sequencing with in-house bioinformatics pipelines that enable comprehensive taxonomic and functional analyses across diverse microbiomes. BGI Genomics, based in Shenzhen, China, operates extensive sequencing centers and a global network to execute clinical-scale metagenomics and ecological microbiome projects. Macrogen, headquartered in Seoul, South Korea, provides end-to-end microbiome services from sample processing to data interpretation, leveraging their global laboratories. Together these firms anchor the service ecosystem, offering standardized protocols, cross-regional batching, and regulatory-savvy data handling to support academic and contract research. Their competition fosters innovation in assay design, data privacy, and reproducibility globally.
Beyond the first tier, Eurofins Genomics offers integrated sequencing workflows that emphasize accuracy, cross-lab compatibility, and scalable throughput for microbiome projects, with headquarters in Luxembourg City, Luxembourg. LC Sciences and Sangon Biotech round out North American and Asian service strengths, with LC Sciences based in Houston, United States and Sangon Biotech headquartered in Shanghai, China, delivering targeted 16S, amplicon, and whole-metagenome sequencing complemented by robust data processing. Genewiz, headquartered in South Plainfield, United States, complements its global scale with targeted microbiome services, including sample QC, library preparation, and downstream analysis through its bioinformatics pipelines. Together, these players exemplify the diversification of service models—from full-service laboratories offering turnkey project management to specialized units delivering modular sequencing and analysis. The competitive environment supports standardization, faster turnaround, and improved alignment with biosafety and regulatory guidelines for industrial, academic, and clinical microbiome research. Their networks enable cross-border collaboration and comparative meta-analyses across diverse ecosystems.
CosmosID, headquartered in Rockville, Maryland, United States, provides metagenomic profiling with rapid taxonomic assignment and resistome analysis, complementing its scientists with user-friendly dashboards and reproducible workflows. PSOMAGEN, based in Rockville, Maryland, United States, offers broad microbiome sequencing services—from 16S communities to whole metagenomes—through flexible project-based pricing, collaborative study design, and rigorous quality controls. Collectively, these firms illustrate the dispersion of microbiome sequencing services across North America, Europe, and Asia, with specialized bioinformatics assets underpinning translational research, environmental monitoring, and industrial biotechnology. As demand grows for standardized data formats and integrated reporting, the market will likely consolidate around platforms that harmonize wet-lab workflows with scalable analytics, enabling researchers to translate complex microbial signatures into actionable insights for health, agriculture, and ecosystem management. Industry collaboration on reference databases, metadata standards, and cross-platform interoperability will determine which firms become preferred partners for multi-site microbiome studies, guiding investment, regulatory alignment, and impact across sectors.
Leading players in the Microbiome Sequencing Services Market include Illumina, Novogene, BGI Genomics, and Macrogen, whose capacities span 16S rRNA gene sequencing, whole-genome shotgun sequencing, metagenomic profiling, and cutting-edge library preparation. Illumina, headquartered in San Diego, United States, is recognized for scalable platforms and broad service offerings that support large-cohort microbiome studies. Novogene, headquartered in Beijing, China, combines high-throughput sequencing with in-house bioinformatics pipelines that enable comprehensive taxonomic and functional analyses across diverse microbiomes. BGI Genomics, based in Shenzhen, China, operates extensive sequencing centers and a global network to execute clinical-scale metagenomics and ecological microbiome projects. Macrogen, headquartered in Seoul, South Korea, provides end-to-end microbiome services from sample processing to data interpretation, leveraging their global laboratories. Together these firms anchor the service ecosystem, offering standardized protocols, cross-regional batching, and regulatory-savvy data handling to support academic and contract research. Their competition fosters innovation in assay design, data privacy, and reproducibility globally.
Beyond the first tier, Eurofins Genomics offers integrated sequencing workflows that emphasize accuracy, cross-lab compatibility, and scalable throughput for microbiome projects, with headquarters in Luxembourg City, Luxembourg. LC Sciences and Sangon Biotech round out North American and Asian service strengths, with LC Sciences based in Houston, United States and Sangon Biotech headquartered in Shanghai, China, delivering targeted 16S, amplicon, and whole-metagenome sequencing complemented by robust data processing. Genewiz, headquartered in South Plainfield, United States, complements its global scale with targeted microbiome services, including sample QC, library preparation, and downstream analysis through its bioinformatics pipelines. Together, these players exemplify the diversification of service models—from full-service laboratories offering turnkey project management to specialized units delivering modular sequencing and analysis. The competitive environment supports standardization, faster turnaround, and improved alignment with biosafety and regulatory guidelines for industrial, academic, and clinical microbiome research. Their networks enable cross-border collaboration and comparative meta-analyses across diverse ecosystems.
CosmosID, headquartered in Rockville, Maryland, United States, provides metagenomic profiling with rapid taxonomic assignment and resistome analysis, complementing its scientists with user-friendly dashboards and reproducible workflows. PSOMAGEN, based in Rockville, Maryland, United States, offers broad microbiome sequencing services—from 16S communities to whole metagenomes—through flexible project-based pricing, collaborative study design, and rigorous quality controls. Collectively, these firms illustrate the dispersion of microbiome sequencing services across North America, Europe, and Asia, with specialized bioinformatics assets underpinning translational research, environmental monitoring, and industrial biotechnology. As demand grows for standardized data formats and integrated reporting, the market will likely consolidate around platforms that harmonize wet-lab workflows with scalable analytics, enabling researchers to translate complex microbial signatures into actionable insights for health, agriculture, and ecosystem management. Industry collaboration on reference databases, metadata standards, and cross-platform interoperability will determine which firms become preferred partners for multi-site microbiome studies, guiding investment, regulatory alignment, and impact across sectors.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
